Clinical Trial

The Effect of Denosumab on Muscle and Strength and Insulin Sensitivity

Name: The Effect of Denosumab on Muscle and Strength and Insulin Sensitivity — clinical trial record (NCT07271771)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: DENMUSIN

Recruiting Phase 4

View on ClinicalTrials.gov →

Summary

Randomized, placebo controlled prospective trial evaluating the effect of denosumab on insulin sensitivity and muscle strength.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-11-26.

Trial Details

NCT Number	NCT07271771
Lead Sponsor	Aarhus University Hospital Collaborators: Sponsor: MD, Professor, DMSc, PhD Bente Lomholt Langdahl
Conditions	Osteoporosis
Enrollment	40 participants
Start Date	2024-05-21
Primary Completion	2027-03-01 (estimated)
Study Completion	2027-03-01 (estimated)
Updated on ClinicalTrials.gov	2025-12-15